News Conference News TCT 2022 RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion Todd Neale September 21, 2022
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017